levodopa has been researched along with Sensitivity and Specificity in 85 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (17.65) | 18.2507 |
| 2000's | 40 (47.06) | 29.6817 |
| 2010's | 27 (31.76) | 24.3611 |
| 2020's | 3 (3.53) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Ceballos-Baumann, AO; Fietzek, UM; Schulz, SJ; Ziegler, K | 1 |
| Ayala, A; Forjaz, MJ; Harmat, M; Janszky, J; Juhász, A; Kovács, N; Martinez-Martin, P; Pintér, D; Rodriguez-Blazquez, C | 1 |
| Baik, JS; Cho, JW; Choi, JH; Jeon, B; Kim, HT; Kim, JM; Kim, JW; Koh, SB; Kwon, OD; Lee, HW; Lee, JY; Ma, HI; Yoon, WT | 1 |
| Bi, F; Chen, Q; Deng, N; Gou, D; Liao, Q; Long, X; Lu, K; Zhou, J | 1 |
| Fox, SH; Li, MH; Mestre, TA; Taati, B | 1 |
| Brandt, G; Canessa, A; Frigo, CA; Isaias, IU; Leporini, A; Maltese, V; Palmisano, C; Pezzoli, G; Pozzi, NG; Volkmann, J | 1 |
| Farzanehfar, P; Horne, M; Khodakarami, H | 1 |
| Asayama, S; Asayama, T; Fujita, K; Ito, H; Kaneko, S; Kusaka, H; Morita, J; Nagashima, M; Nakamura, M; Nakamura, S; Nakano, S; Nishii, M; Oki, M; Saito, A; Tsuge, A; Wate, R | 1 |
| Holiga, Š; Jech, R; Möller, HE; Mueller, K; Růžička, E; Schroeter, ML; Sieger, T; Vymazal, J | 1 |
| Cardoso, MA; de Carvalho, KA; Marson, BM; Pontarolo, R; Pontes, FL; Ribeiro, RP; Vilhena, Rde O | 1 |
| Barbosa, ER; Chien, HF; Santos, JG | 1 |
| Alexiou, A; Psiha, M; Vlamos, P | 1 |
| Dolbert, T; Frankemolle, AM; McIntyre, CC; Noecker, AM; Shamir, RR; Walter, BL | 1 |
| Berganzo, K; Gomez-Esteban, JC; Kaufmann, H; Martinez, J; Norcliffe-Kaufmann, L; Palma, JA; Tijero, B | 1 |
| Cheng, LG; Du, LJ; Gao, J; He, W; Li, S | 1 |
| Cerquetti, D; Fariña, S; Merello, M; Morisset, P; Rossi, M; Wilken, M | 1 |
| Alonso-Frech, F; De la Casa-Fages, B; Grandas, F | 1 |
| Benetin, J; Bötzel, K; Brozová, H; Růzicka, E; Valkovic, P | 1 |
| Karim, MM; Kim, WH; Lee, SH | 1 |
| Lima, JL; Lopes, JA; Marques, KL; Santos, JL | 1 |
| Aberle, J; Baker, WL; Coleman, CI; Kluger, J; Patel, AA; Silver, D; White, CM | 1 |
| Blume, SR; Cass, DK; Tseng, KY | 1 |
| Kroenke, K; Murck, H; Stacy, MA | 1 |
| Estévez, S; Merello, M; Perez-Lloret, S | 1 |
| Barbosa, ER; Chien, HF; Melo, LM | 1 |
| Elmongy, A; Gabr, W; Hazem, M; Razek, AA; Zakareyia, S | 1 |
| Barthlen, W; Blankenstein, O; Mohnike, K; Mohnike, W | 1 |
| Endres, CJ; Hayashi, T; Iida, H; Kumakura, Y; Matsubara, K; Minato, K; Watabe, H | 1 |
| Bonfim, RR; Byrro, RM; César, IC; Gomes, SA; Mundim, IM; Pianetti, GA; Santana E Silva Cardoso, FF; Souza Teixeira, L | 1 |
| Delépée, R; Maunit, B; Salwiński, A | 1 |
| Damos, FS; de Oliveira, AB; dos Santos, WT; Leite, FR; Maroneze, CM; Silva Luz, Rde C | 1 |
| Cai, Z; Hu, M; Hu, Q; Wei, F; Xu, G; Yang, J; Yu, H | 1 |
| Chemaitilly, W; Hua, C; Lukose, RC; Merchant, TE; Wu, S | 1 |
| Bryant, MS; Hou, JG; Protas, EJ; Rintala, DH | 1 |
| Liu, CH; Tseng, WL; Yu, CJ | 1 |
| Jančić Stojanović, B; Malenović, A; Stamenković, I; Vemić, A | 1 |
| Langston, JW; Protell, PH; Tan, LC; Togasaki, DM | 1 |
| Gielen, SC; Horstink, MW; Keijsers, NL | 1 |
| Bandmann, O; Deuschl, G; Goertz, M; Hefter, H; Hoffmann, G; Jost, W; Müller, U; Oertel, W; Zöfel, P; Zschocke, J | 1 |
| Morrish, PK | 1 |
| Abe, K; Hotta, K; Igarashi, K; Kasuya, F; Sakoda, S | 1 |
| Masuda, N; Nagae, Y; Nakashima, A; Niina, M; Saxer, C | 1 |
| Bailey, DL; Brooks, DJ; Pavese, N; Remy, P; Whone, AL | 1 |
| Djaldetti, R; Lampl, Y; Lorberboym, M; Melamed, E; Sadeh, M | 1 |
| Turnbull, C | 1 |
| Kanehatsu, R; Kiguchi, K; Ling, E; Shirai, K | 1 |
| Fang, YZ; He, PG; Ning, L; Wang, AF; Wang, J; Zhang, SH; Zhou, Y | 1 |
| Deyong, H; Funan, C; Yingxue, Z; Zhujun, Z | 1 |
| Fang, Y; Wang, J | 1 |
| Blankenstein, O; Christesen, HT; De Lonlay, J; Fékété, CN; Hussain, K; Koopmans, KP; Minn, H; Mohnike, K; Mohnike, W; Mutair, A; Otonkoski, T; Rahier, J; Ribeiro, M; Schoenle, E | 1 |
| Becker, B; Hagenah, JM; Hedrich, K; Klein, C; Pramstaller, PP; Seidel, G | 1 |
| Dhawan, V; Eidelberg, D; Ma, Y; Spetsieris, PG; Tang, C | 1 |
| Fonteh, AN; Harrington, MG; Harrington, RJ | 1 |
| Bi, LL; Chen, XY; Jia, YY; Luo, XX; Wen, AD; Zhong, DF | 1 |
| Baccard, M; Basset-Seguin, N; Bousquet, B; Cassinat, B; Dubertret, L; Garnier, JP; Kerob, D; Le Bricon, T; Lebbé, C; Letellier, S; Morel, P; Stoitchkov, K | 1 |
| Safavi, A; Tohidi, M | 1 |
| Cheng, TL; Tseng, WL; Wu, HP | 1 |
| Flieger, M; Novotná, J; Olsovská, J; Spízek, J | 1 |
| Lee, PW; McKeown, MJ; Palmer, SJ; Wang, Z | 1 |
| Chen, Y; Cheong, S; Guo, C; Lim, L; Reboud, J; Tang, K; Zhang, Q | 1 |
| Brown, P; Doyle, LM; Lees, AJ; Williams, DR | 1 |
| Ho, JA; Hsu, WL; Huang, CC; Liao, WC; Viswanathan, S | 1 |
| Daniel, SE; Eve, DJ; Foster, OJ; Kingsbury, A; Lees, AJ; Marsden, CD; Nisbet, AP | 1 |
| Hawkins, RA | 1 |
| Enjaume, C; Oliver, I; Pienkowski, C; Rochiccioli, P; Tauber, MT | 1 |
| Hossain, MA; Weiner, N | 1 |
| Bowes, SG; Charlett, A; Dobbs, RJ; Dobbs, SM; Hunt, WB; Kirollos, C; Kosik, R; Mozol, K; Nicholson, PW; O'Neill, CJ; Purkiss, AG; Weller, C | 1 |
| Bringmann, G; Clement, HW; Feineis, D; Grote, C; Riederer, P; Sontag, KH; Wesemann, W | 1 |
| Durrieu, G; Llau, ME; Montastruc, JL; Rascol, O; Senard, JM; Tran, MA | 1 |
| Brefel-Courbon, C; Fabre, N; Rascol, O | 1 |
| Bunzow, JR; Chester, JA; Dziewczapolski, G; Falzone, TL; Fang, Y; Gershanik, O; Grandy, DK; Larson, JL; Low, MJ; McDougall, JA; Phillips, TJ; Pugsley, TA; Rubinstein, M; Saez, C; Zhang, G | 1 |
| De Weerdt, W; Dom, R; Lesaffre, E; Nieuwboer, A | 1 |
| Armengol, JR; Borruel, N; Casellas, F; de Torres, I; Lopez, J; Malagelada, JR; Saperas, E; Vergara, M | 1 |
| Agid, Y; Arnulf, I; Bejjani, BP; Bonnet, AM; Clavier, I; Damier, P; Jaillon, C | 1 |
| Amenta, F; Barbanti, P; Bronzetti, E; Calderaro, C; Caronti, B; Cerbo, R; Fabbrini, G; Felici, L; Lenzi, GL; Meco, G; Ricci, A; Stocchi, F | 1 |
| Asselman, P; Brown, P; Buckwell, D; Lees, AJ; Manson, AJ; O'Sullivan, JD | 1 |
| Albanese, A; Colosimo, C; Moro, E; Rossi, P; Tonali, P | 1 |
| Dolezalová, M; Tkaczyková, M | 1 |
| Bi, S; Bian, N; Liu, F; Yang, Y; Zhang, F; Zhang, J | 1 |
| Clarke, CE; Davies, P | 1 |
| Fountain, ST; Li, W; Rossi, DT | 1 |
| Bamias, C; Hardy, P; Pocock, S; Warner, J; White, IR | 1 |
| Arafah, BM; Biller, BM; Bonert, V; Chipman, JJ; Cook, DM; Hartman, ML; Kleinberg, DL; Samuels, MH; Stavrou, S; Zagar, A | 1 |
| August, TF; Bayne, WF; Eisenhandler, R; Musson, DG; Titus, DC; Yeh, KC | 1 |
2 review(s) available for levodopa and Sensitivity and Specificity
| Article | Year |
|---|---|
Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis.
Topics: Databases, Bibliographic; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2009 |
Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease.
Topics: Apomorphine; Diagnostic Tests, Routine; Humans; Levodopa; Parkinson Disease; Sensitivity and Specificity | 2000 |
16 trial(s) available for levodopa and Sensitivity and Specificity
| Article | Year |
|---|---|
The Minimal Clinically Relevant Change of the FOG Score.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Minimal Clinically Important Difference; Parkinson Disease; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; Video Recording | 2020 |
Push-and-release test predicts Parkinson fallers and nonfallers better than the pull test: comparison in OFF and ON medication states.
Topics: Accidental Falls; Aged; Antiparkinson Agents; Ataxia; Diagnostic Techniques, Neurological; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Postural Balance; Predictive Value of Tests; Risk; Sensitivity and Specificity; Severity of Illness Index | 2008 |
Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy.
Topics: Activities of Daily Living; Behavioral Symptoms; Carbidopa; Disability Evaluation; Dopamine Agents; Female; Humans; Levodopa; Male; Motor Activity; Outcome Assessment, Health Care; Parkinson Disease; Sensitivity and Specificity; Severity of Illness Index; Surveys and Questionnaires | 2010 |
Predicting the probability of abnormal stimulated growth hormone response in children after radiotherapy for brain tumors.
Topics: Adolescent; Arginine; Biomarkers; Brain Neoplasms; Child; Child, Preschool; Craniopharyngioma; Ependymoma; Feasibility Studies; Female; Glioma; Human Growth Hormone; Humans; Hypothalamus; Infant; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Levodopa; Logistic Models; Male; Models, Biological; Predictive Value of Tests; Probability; Prospective Studies; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; ROC Curve; Sensitivity and Specificity | 2012 |
The phenylalanine loading test in the differential diagnosis of dystonia.
Topics: Administration, Oral; Adult; Diagnosis, Differential; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Phenylalanine; Predictive Value of Tests; Reference Values; Sensitivity and Specificity; Time Factors; Tyrosine | 2003 |
A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study.
Topics: Algorithms; Antiparkinson Agents; Canada; Dihydroxyphenylalanine; Dopamine Agents; France; Germany; Humans; Image Interpretation, Computer-Assisted; Indoles; Levodopa; Parkinson Disease; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; United Kingdom | 2004 |
123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Cerebrovascular Disorders; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Organometallic Compounds; Parkinson Disease, Secondary; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2004 |
Distinguishing early-onset PD from dopa-responsive dystonia with transcranial sonography.
Topics: Adult; Age of Onset; Antiparkinson Agents; Diagnosis, Differential; Dystonia; Female; Humans; In Vitro Techniques; Levodopa; Middle Aged; Parkinson Disease; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Doppler, Transcranial | 2006 |
The effect of Madopar on the pharmacokinetics of ropinirole in healthy Chinese volunteers.
Topics: Adult; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Asian People; Benserazide; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Female; Humans; Indoles; Levodopa; Linear Models; Male; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2007 |
Objective measurement of activation of rigidity: diagnostic, pathogenetic and therapeutic implications in parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Hand Strength; Humans; Isometric Contraction; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Physical Exertion; Reproducibility of Results; Sensitivity and Specificity; Torque; Trihexyphenidyl | 1996 |
A study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients.
Topics: Adult; Aged; Antiparkinson Agents; Apomorphine; Blood Pressure; Dopamine; Epinephrine; Female; Heart Rate; Human Growth Hormone; Humans; Hypothalamus; Levodopa; Male; Middle Aged; Norepinephrine; Parkinson Disease; Peripheral Nervous System; Prolactin; Sensitivity and Specificity | 1996 |
The impact of delaying gastric emptying by either meal substrate or drug on the [13C]-urea breath test.
Topics: Adult; Aged; Aged, 80 and over; Breath Tests; Carbon Isotopes; Dopamine Agents; Duodenal Ulcer; Female; Food, Formulated; Gastric Emptying; Helicobacter Infections; Helicobacter pylori; Humans; Levodopa; Male; Middle Aged; Premedication; Reproducibility of Results; Sensitivity and Specificity; Stomach Ulcer; Time Factors; Urea; Water | 1999 |
Dyskinesias assessment in Phase II studies.
Topics: Biological Transport; Brain; Clinical Protocols; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Levodopa; Sensitivity and Specificity | 1999 |
An ambulatory dyskinesia monitor.
Topics: Adult; Aged; Antiparkinson Agents; Dyskinesia, Drug-Induced; Electrophysiology; Female; Humans; Levodopa; Male; Middle Aged; Monitoring, Ambulatory; Parkinson Disease; Sensitivity and Specificity; Severity of Illness Index | 2000 |
Acute challenge with apomorphine and levodopa in Parkinsonism.
Topics: Age of Onset; Aged; Antiparkinson Agents; Apomorphine; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Sensitivity and Specificity | 2000 |
Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency.
Topics: Adult; Aged; Aging; Arginine; Body Mass Index; Diagnostic Techniques, Endocrine; Drug Combinations; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin-Like Growth Factor I; Levodopa; Male; Metabolic Diseases; Middle Aged; Sensitivity and Specificity; Sex Characteristics; Stimulation, Chemical | 2002 |
67 other study(ies) available for levodopa and Sensitivity and Specificity
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Which Scale Best Detects Treatment Response of Tremor in Parkinsonism?
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Deep Brain Stimulation; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinsonian Disorders; Sensitivity and Specificity; Severity of Illness Index; Tremor | 2020 |
Neuropsychiatric Traits Associated with Refractory Impulse Control Disorder in Parkinson's Disease.
Topics: Anger; Antiparkinson Agents; Case-Control Studies; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Obsessive Behavior; Parkinson Disease; Risk Factors; Sensitivity and Specificity; Treatment Failure | 2019 |
Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease.
Topics: Biomarkers; Case-Control Studies; Early Diagnosis; Female; Humans; Levodopa; Male; MicroRNAs; Middle Aged; Parkinson Disease; Sensitivity and Specificity | 2021 |
Automated assessment of levodopa-induced dyskinesia: Evaluating the responsiveness of video-based features.
Topics: Aged; Antiparkinson Agents; Biomechanical Phenomena; Deep Learning; Dyskinesia, Drug-Induced; Female; Humans; Image Interpretation, Computer-Assisted; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Reported Outcome Measures; Sensitivity and Specificity; Severity of Illness Index; Video Recording | 2018 |
Sit-to-walk performance in Parkinson's disease: A comparison between faller and non-faller patients.
Topics: Accidental Falls; Aged; Aged, 80 and over; Benserazide; Case-Control Studies; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Postural Balance; Quality of Life; Sensitivity and Specificity; Sitting Position; Walking | 2019 |
The Use of Data from the Parkinson's KinetiGraph to Identify Potential Candidates for Device Assisted Therapies.
Topics: Aged; Algorithms; Deep Brain Stimulation; Dyskinesias; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Sensitivity and Specificity; Tremor | 2019 |
Levodopa challenge test and (123) I-metaiodobenzylguanidine scintigraphy for diagnosing Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors | 2013 |
Motor matters: tackling heterogeneity of Parkinson's disease in functional MRI studies.
Topics: Antiparkinson Agents; Basal Ganglia; Carbidopa; Disability Evaluation; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Psychomotor Performance; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2013 |
A new HILIC-MS/MS method for the simultaneous analysis of carbidopa, levodopa, and its metabolites in human plasma.
Topics: Aged; Antiparkinson Agents; Carbidopa; Chromatography, Liquid; Drug Monitoring; Drug Stability; Female; Humans; Hydrophobic and Hydrophilic Interactions; Levodopa; Linear Models; Male; Middle Aged; Parkinson Disease; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2014 |
Specificity and sensibility of 9-Itens Wearing-off Questionnaire in Brazilian Parkinson disease patient sample.
Topics: Adult; Aged; Aged, 80 and over; Brazil; Cross-Sectional Studies; Dopamine Agents; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Statistics, Nonparametric; Surveys and Questionnaires; Translations | 2014 |
Towards an expert system for accurate diagnosis and progress monitoring of Parkinson's disease.
Topics: Algorithms; Antiparkinson Agents; Biomarkers; Carbidopa; Deep Brain Stimulation; Disease Progression; Drug Therapy, Combination; Expert Systems; Humans; Levodopa; Parkinson Disease; Sensitivity and Specificity | 2015 |
A method for predicting the outcomes of combined pharmacologic and deep brain stimulation therapy for Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Brain; Combined Modality Therapy; Deep Brain Stimulation; Female; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2014 |
Orthostatic hypotension in Parkinson disease: how much you fall or how low you go?
Topics: Age Factors; Aged; Antiparkinson Agents; Blood Pressure; Europe; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Sensitivity and Specificity; Severity of Illness Index; Surveys and Questionnaires; United States | 2015 |
Ultrasound Strain Elastography in Assessment of Muscle Stiffness in Acute Levodopa Challenge Test: A Feasibility Study.
Topics: Aged; Antiparkinson Agents; Elastic Modulus; Elasticity Imaging Techniques; Feasibility Studies; Humans; Image Interpretation, Computer-Assisted; Levodopa; Male; Middle Aged; Muscle, Skeletal; Parkinson Disease; Reproducibility of Results; Sensitivity and Specificity; Stress, Mechanical | 2016 |
Facial tremors in patients with and without parkinsonism.
Topics: Aged; Aged, 80 and over; Dopamine Agents; Face; Female; Humans; Levodopa; Male; Parkinsonian Disorders; Retrospective Studies; Sensitivity and Specificity; Tremor | 2016 |
Effect of subthalamic nucleus deep brain stimulation on balance in Parkinson's disease: A static posturographic analysis.
Topics: Aged; Antiparkinson Agents; Case-Control Studies; Deep Brain Stimulation; Female; Gait; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Postural Balance; Sensitivity and Specificity; Subthalamic Nucleus | 2017 |
Simultaneous determination of levodopa and carbidopa by synchronous fluorescence spectrometry using double scans.
Topics: Carbidopa; Levodopa; Pharmaceutical Preparations; Sensitivity and Specificity; Spectrometry, Fluorescence; Time Factors | 2008 |
Simultaneous chemiluminometric determination of levodopa and benserazide in a multi-pumping flow system with multivariate calibration.
Topics: Antiparkinson Agents; Automation; Benserazide; Calibration; Flow Injection Analysis; Levodopa; Luminescent Measurements; Neural Networks, Computer; Pharmaceutical Preparations; Principal Component Analysis; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Stepping test in mice: a reliable approach in determining forelimb akinesia in MPTP-induced Parkinsonism.
Topics: Animals; Antiparkinson Agents; Cell Count; Disease Models, Animal; Forelimb; Hypokinesia; Lameness, Animal; Levodopa; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neurologic Examination; Parkinsonian Disorders; Predictive Value of Tests; Sensitivity and Specificity; Substantia Nigra | 2009 |
Does clinical intolerance to a diagnostic acute levodopa challenge differentiate multiple system atrophy from PD?
Topics: Diagnosis, Differential; Dopamine Agents; Female; Follow-Up Studies; Humans; Levodopa; Male; Multiple System Atrophy; Parkinson Disease; Sensitivity and Specificity | 2009 |
Identification of wearing-off manifestations (reduction of levodopa effect) in Parkinson's disease using specific questionnaire and comparison of the results with routine ambulatory evaluations.
Topics: Aged; Antiparkinson Agents; Drug Tolerance; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sensitivity and Specificity; Severity of Illness Index; Surveys and Questionnaires | 2010 |
Idiopathic Parkinson disease effect of levodopa on apparent diffusion coefficient value of the brain.
Topics: Aged; Antiparkinson Agents; Brain; Brain Mapping; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Female; Humans; Levodopa; Male; Parkinson Disease; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2011 |
Positron emission tomography/computed tomography diagnostics by means of fluorine-18-L-dihydroxyphenylalanine in congenital hyperinsulinism.
Topics: Congenital Hyperinsulinism; Fluorine Radioisotopes; Humans; Infant; Levodopa; Pancreatectomy; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Sensitivity of kinetic macro parameters to changes in dopamine synthesis, storage, and metabolism: a simulation study for [¹⁸F]FDOPA PET by a model with detailed dopamine pathway.
Topics: Animals; Brain; Dihydroxyphenylalanine; Dopamine; Levodopa; Linear Models; Macaca fascicularis; Models, Neurological; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Development and validation of a high-performance liquid chromatography-electrospray ionization-MS/MS method for the simultaneous quantitation of levodopa and carbidopa in human plasma.
Topics: Administration, Oral; Carbidopa; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Levodopa; Male; Methyldopa; Reproducibility of Results; Sensitivity and Specificity; Tablets; Tandem Mass Spectrometry | 2011 |
Continuous-flow step gradient mass spectrometry based method for the determination of kinetic parameters of immobilized mushroom tyrosinase in equilibrating conditions: comparison with free enzyme.
Topics: Agaricales; Bioreactors; Enzymes, Immobilized; Kinetics; Levodopa; Mass Spectrometry; Monophenol Monooxygenase; Reproducibility of Results; Sensitivity and Specificity; Temperature; Tyrosine | 2011 |
Development of a sensor for L-Dopa based on Co(DMG)(2)ClPy/multi-walled carbon nanotubes composite immobilized on basal plane pyrolytic graphite electrode.
Topics: Buffers; Cobalt; Electrochemistry; Electrodes; Graphite; Hydrogen-Ion Concentration; Levodopa; Nanotubes, Carbon; Oxidation-Reduction; Sensitivity and Specificity; Tablets | 2012 |
Citrate-capped Mn-modified CdSe/CdS quantum dots as luminescent probes for levodopa detection in aqueous solution.
Topics: Antiparkinson Agents; Cadmium Compounds; Citric Acid; Levodopa; Luminescence; Manganese; Pharmaceutical Preparations; Quantum Dots; Selenium Compounds; Sensitivity and Specificity; Spectrometry, Fluorescence; Sulfides | 2012 |
Reliability of the non-instrumented walk test in persons with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Dopamine Agents; Exercise Test; Female; Gait; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Reproducibility of Results; Sensitivity and Specificity; Walking | 2013 |
Fluorescence assay of catecholamines based on the inhibition of peroxidase-like activity of magnetite nanoparticles.
Topics: Catalysis; Catecholamines; Catechols; Dopamine; Electrochemical Techniques; Epinephrine; Fluorescence; Fluorescent Dyes; Humans; Hydrogen Peroxide; Levodopa; Limit of Detection; Magnetite Nanoparticles; Male; Microscopy, Electron, Transmission; Monophenol Monooxygenase; Norepinephrine; Oxidation-Reduction; Peroxidase; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Surface Properties; Young Adult | 2012 |
Chaotropic agents in liquid chromatographic method development for the simultaneous analysis of levodopa, carbidopa, entacapone and their impurities.
Topics: Antiparkinson Agents; Carbidopa; Catechols; Chromatography, Reverse-Phase; Drug Contamination; Levodopa; Nitriles; Particle Size; Reproducibility of Results; Sensitivity and Specificity; Trifluoroacetic Acid | 2013 |
The hyperkinetic abnormal movements scale: a tool for measuring levodopa-induced abnormal movements in squirrel monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Female; Hyperkinesis; Levodopa; Male; Observer Variation; Random Allocation; Reproducibility of Results; Saimiri; Sensitivity and Specificity; Striatonigral Degeneration; Surveys and Questionnaires | 2002 |
Automatic assessment of levodopa-induced dyskinesias in daily life by neural networks.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Diagnosis, Computer-Assisted; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Neural Networks, Computer; Neurologic Examination; Observer Variation; Parkinson Disease; Sensitivity and Specificity | 2003 |
REAL and CALM: what have we learned?
Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Corpus Striatum; Disease Progression; Dopamine; Feasibility Studies; Humans; Indoles; Levodopa; Neurons; Neuroprotective Agents; Parkinson Disease; Pramipexole; Putamen; Reference Values; Sensitivity and Specificity; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Determination of cabergoline and L-dopa in human plasma using liquid chromatography-tandem mass spectrometry.
Topics: Adult; Cabergoline; Case-Control Studies; Chromatography, Liquid; Dopamine Agonists; Ergolines; Humans; Levodopa; Middle Aged; Reproducibility of Results; Schizophrenia; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2003 |
Simultaneous determination of levodopa and 3-O-methyldopa in human plasma by liquid chromatography with electrochemical detection.
Topics: Calibration; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Levodopa; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2004 |
Vascular parkinsonism--an important update.
Topics: Antiparkinson Agents; Diagnosis, Differential; Diagnostic Imaging; Humans; Intracranial Arteriosclerosis; Levodopa; Neurologic Examination; Neuropsychological Tests; Olfaction Disorders; Parkinson Disease; Parkinson Disease, Secondary; Sensitivity and Specificity | 2005 |
Reexamination of phenoloxidase in larval circulating hemocytes of the silkworm, Bombyx mori.
Topics: Animals; Bombyx; Granulocytes; Hemocytes; Histocytochemistry; Larva; Levodopa; Monophenol Monooxygenase; Sensitivity and Specificity; Staining and Labeling | 2005 |
Determination of levodopa methyl ester and its metabolites in rat serum by CZE with amperometric detection.
Topics: Animals; Biotransformation; Buffers; Electrochemistry; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Levodopa; Male; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Microdialysis sampling and high-performance liquid chromatography with chemiluminescence detection for in-vivo on-line determination and study of the pharmacokinetics of levodopa in blood.
Topics: Chromatography, High Pressure Liquid; Ferricyanides; Levodopa; Luminescence; Microdialysis; Phenobarbital; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Determination, purity assessment and chiral separation of levodopa methyl ester in bulk and formulation pharmaceuticals.
Topics: Chromatography, High Pressure Liquid; Electrochemistry; Levodopa; Pharmaceutical Preparations; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism | 2006 |
Proposal for a standardized protocol for 18F-DOPA-PET (PET/CT) in congenital hyperinsulinism.
Topics: Congenital Hyperinsulinism; Diagnosis, Differential; Fluorine Radioisotopes; Humans; Infant; Levodopa; Pancreas; Positron-Emission Tomography; Sensitivity and Specificity; Surveys and Questionnaires | 2006 |
Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.
Topics: Aged; Algorithms; Antiparkinson Agents; Biomarkers; Brain; Cerebrovascular Circulation; Deep Brain Stimulation; Female; Glucose; Humans; Image Processing, Computer-Assisted; Levodopa; Male; Metabolic Networks and Pathways; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Sensitivity and Specificity; Software | 2007 |
Quantification of free amino acids and dipeptides using isotope dilution liquid chromatography and electrospray ionization tandem mass spectrometry.
Topics: Amino Acids; Body Fluids; Cerebrospinal Fluid; Chromatography, Liquid; Dipeptides; Humans; Ions; Levodopa; Mass Spectrometry; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Time Factors | 2007 |
Clinical value of combined determination of plasma L-DOPA/tyrosine ratio, S100B, MIA and LDH in melanoma.
Topics: Aged; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Female; Humans; Levodopa; Male; Melanoma; Middle Aged; Prospective Studies; S100 Proteins; Sensitivity and Specificity; Skin Neoplasms; Survival Analysis; Tyrosine | 2007 |
Simultaneous kinetic determination of levodopa and carbidopa by H-point standard addition method.
Topics: Antiparkinson Agents; Carbidopa; Ethanol; Excipients; Hydrogen-Ion Concentration; Kinetics; Levodopa; Osmolar Concentration; Oxidation-Reduction; Pharmaceutical Preparations; Phenanthrolines; Sensitivity and Specificity; Solubility; Spectrophotometry; Surface-Active Agents; Tablets; Temperature | 2007 |
Phosphate-modified TiO2 nanoparticles for selective detection of dopamine, levodopa, adrenaline, and catechol based on fluorescence quenching.
Topics: Biosensing Techniques; Catechols; Dopamine; Epinephrine; Fluorescence; Levodopa; Nanoparticles; Pharmaceutical Preparations; Phosphates; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Titanium | 2007 |
Assay of tyrosine hydroxylase based on high-performance liquid chromatography separation and quantification of L-dopa and L-tyrosine.
Topics: Biological Assay; Chromatography, High Pressure Liquid; Dopamine Agents; Drug Stability; Enzyme Activation; Hydrogen-Ion Concentration; Levodopa; Oxidation-Reduction; Reproducibility of Results; Sensitivity and Specificity; Temperature; Time Factors; Tyrosine; Tyrosine 3-Monooxygenase | 2007 |
Spectral clustering of fMRI data within regions of interest: clarification of L-dopa effects in Parkinson's disease.
Topics: Algorithms; Antiparkinson Agents; Brain; Brain Mapping; Cluster Analysis; Humans; Image Interpretation, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Parkinson Disease; Prognosis; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Treatment Outcome | 2007 |
Compact microelectrode array system: tool for in situ monitoring of drug effects on neurotransmitter release from neural cells.
Topics: Animals; Biosensing Techniques; Collagen; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Electrochemistry; Levodopa; Microarray Analysis; Microelectrodes; Neurons; Neurotransmitter Agents; PC12 Cells; Potassium; Rats; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2008 |
The auditory startle response in parkinsonism may reveal the extent but not type of pathology.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Auditory Pathways; Blinking; Brain Stem; Dementia; Diagnosis, Differential; Facial Muscles; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neck Muscles; Ocular Motility Disorders; Parkinsonian Disorders; Predictive Value of Tests; Reflex, Startle; Sensitivity and Specificity; Supranuclear Palsy, Progressive; Tauopathies | 2008 |
Rapid analysis of L-dopa in urine samples using gold nanoelectrode ensembles.
Topics: Carbon; Electrochemistry; Electrodes; Flow Injection Analysis; Gold; Humans; Levodopa; Nanostructures; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2007 |
Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Autoradiography; Basal Ganglia; Dopamine Agents; Enkephalins; Female; Gene Expression; Humans; Levodopa; Male; Middle Aged; Neostriatum; Parkinson Disease; Protein Precursors; RNA, Messenger; Sensitivity and Specificity; Tachykinins | 1995 |
Pancreatic tumors: imaging with PET.
Topics: Adenocarcinoma; Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Neuroendocrine Tumors; Pancreatic Neoplasms; Sensitivity and Specificity; Serotonin; Tomography, Emission-Computed | 1995 |
[Statistic study of 5,473 somatotropin secretion stimulation pharmacologic tests (n=9). Proposed weighting coefficient].
Topics: Adolescent; Age Determination by Skeleton; Arginine; Betaxolol; Child; Child, Preschool; Clonidine; Confidence Intervals; Data Interpretation, Statistical; Female; Glucagon; Growth Disorders; Growth Hormone; Humans; Insulin; Levodopa; Male; Normal Distribution; Ornithine; Propranolol; Puberty; Radioimmunoassay; Retrospective Studies; Sensitivity and Specificity | 1993 |
Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biopterins; Brain Diseases; Carbidopa; Corpus Striatum; Cyclic AMP; Disease Models, Animal; Dopamine; Dopamine D2 Receptor Antagonists; Homovanillic Acid; Levodopa; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred F344; Receptors, Dopamine D1; Receptors, Dopamine D2; Sensitivity and Specificity; Substantia Nigra; Time Factors | 1993 |
Biochemical lesions of the nigrostriatal system by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) and derivatives.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carbolines; Corpus Striatum; Dopamine; Electrochemistry; Levodopa; Male; Neurotoxins; Rats; Rats, Wistar; Sensitivity and Specificity; Substantia Nigra | 1995 |
[Parkinson "plus"].
Topics: Antiparkinson Agents; Humans; Levodopa; Nervous System Diseases; Parkinson Disease; Sensitivity and Specificity | 1997 |
Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acid Sequence; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Depressants; Clozapine; Cocaine; Corpus Striatum; Dopamine; Dopamine Agents; Ethanol; Genotype; Humans; Levodopa; Locomotion; Maternal Behavior; Methamphetamine; Mice; Mice, Knockout; Molecular Sequence Data; Motor Activity; Mutagenesis, Site-Directed; Narcotics; Nucleus Accumbens; Receptors, Dopamine D2; Receptors, Dopamine D4; Sensitivity and Specificity; Substantia Nigra; Transcription, Genetic | 1997 |
A frequency and correlation analysis of motor deficits in Parkinson patients.
Topics: Adult; Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Drug Therapy, Combination; Female; Humans; Incidence; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Prognosis; Psychomotor Disorders; Psychomotor Performance; Selegiline; Sensitivity and Specificity; Severity of Illness Index; Surveys and Questionnaires; Time Factors | 1998 |
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Binding, Competitive; Brain; Cell Count; Dopamine Agonists; Female; Humans; Levodopa; Lymphocytes; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Radioligand Assay; Receptors, Dopamine; Sensitivity and Specificity; Treatment Outcome | 1999 |
Direct high-performance liquid chromatographic determination of the enantiomeric purity of levodopa and methyldopa: comparison with pharmacopoeial polarimetric methods.
Topics: Chromatography, High Pressure Liquid; Czech Republic; Europe; Evaluation Studies as Topic; Levodopa; Ligands; Methyldopa; Optical Rotation; Pharmacopoeias as Topic; Reproducibility of Results; Sensitivity and Specificity; Solvents; Stereoisomerism; Teicoplanin | 1999 |
Differential pulse voltammetric indirect determination of aluminium in drinking waters, blood, urine, hair, and medicament samples using L-dopa under alkaline conditions.
Topics: Aluminum; Drug Contamination; Electrochemistry; Female; Hair; Humans; Hydrogen-Ion Concentration; Levodopa; Male; Sensitivity and Specificity; Water Pollution, Chemical | 2000 |
Development and validation of a semi-automated method for L-dopa and dopamine in rat plasma using electrospray LC/MS/MS.
Topics: Animals; Automation; Chromatography, Liquid; Dopamine; Hydrogen-Ion Concentration; Levodopa; Rats; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2000 |
Randomized clinical trials with added rescue medication: some approaches to their analysis and interpretation.
Topics: Activities of Daily Living; Antiparkinson Agents; Bromocriptine; Humans; Indoles; Levodopa; Multicenter Studies as Topic; Parkinson Disease; Randomized Controlled Trials as Topic; Regression Analysis; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2001 |
Simultaneous high-performance liquid chromatographic analysis of carbidopa, levodopa and 3-O-methyldopa in plasma and carbidopa, levodopa and dopamine in urine using electrochemical detection.
Topics: Carbidopa; Chromatography, High Pressure Liquid; Dopamine; Electrochemistry; Humans; Levodopa; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 1990 |